Gastric myoelectric activity in alder adults treated with cisapride for gastro-oesophageal reflux disease

W. C. Orr, M. Zhang, J. McClanahan, S. Sloan, J. D.Z. Chen

Research output: Contribution to journalArticlepeer-review

Abstract

Background: The incidence of both gastro-oesophageal reflux disease (GERD) and upper gastrointestinal motility disorders appears to increase with age. However, there is a dearth of data concerning the utility of a prokinetic agent such as cisapride in the treatment of older adults with symptomatic GERD. Aim: To investigate the incidence of electrogastrographic abnormalities in older adults with and without GERD symptoms, as well as the effect of cisapride therapy on symptoms of GERD and electrogastrographic responses. Methods: We report on 18 older adults with symptomatic GERD and 10 older adult controls (mean ages 71 and 75 years, respectively). Subjects underwent electrogastrographic evaluation pre- and postprandially under baseline conditions and after 1 month of treatment with 10 mg q.d.s. of cisapride. Results: Heartburn frequency and postprandial fullness were both significantly (P < 0.05) reduced after cisapride treatment. Acid contact time was not significantly changed. The percentage of 2-4 cpm activity in the electrogastrographic analysis was significantly (P < 0.05) increased with cisapride treatment, and the instability coefficient was significantly (P < 0.05) diminished with cisapride treatment. Conclusions: Enhanced gastric functioning and reduction in heartburn suggest that cisapride is efficacious in the treatment of older adults with symptomatic GERD, and that gastric dysrhythmias and postprandial fullness are resolved with cisapride treatment.

Original languageEnglish (US)
Pages (from-to)337-343
Number of pages7
JournalAlimentary Pharmacology and Therapeutics
Volume14
Issue number3
DOIs
StatePublished - 2000

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Gastric myoelectric activity in alder adults treated with cisapride for gastro-oesophageal reflux disease'. Together they form a unique fingerprint.

Cite this